Related Experiment Video
Updated: Apr 26, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
Devices and topical agents for rosacea management.
Yasaman Mansouri, Gary Goldenberg1
1Department of Dermatology, Mount Sinai Hospital, 5 E 98th St, 5th Floor, New York, NY 10029-6574, USA. garygoldenbergmd@gmail.com.
Rosacea is a chronic inflammatory skin condition affecting facial skin. This review covers available devices and topical agents for managing rosacea symptoms, as no cure currently exists.
Area of Science:
- Dermatology
- Inflammatory skin conditions
Background:
- Rosacea is a chronic inflammatory facial skin condition.
- It primarily affects light-skinned individuals and presents with subtypes.
- Diffuse facial erythema is a common and persistent symptom.
Purpose of the Study:
- To review current management options for rosacea.
- To discuss available devices and topical agents for rosacea treatment.
Main Methods:
- Literature review of existing studies and treatments.
- Analysis of devices and topical agents for rosacea management.
Main Results:
- Various treatment modalities can reduce rosacea signs and symptoms.
- Both devices and topical agents are available for management.
Conclusions:
- While rosacea has no cure, its symptoms can be effectively managed.
- This review provides an overview of current therapeutic options.
Related Concept Videos
Acne Infection
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Atherosclerosis III: Management
Antidepressant Drugs: MAOIs and Other Agents
Ophthalmic Drug Delivery Systems
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

